Analystreport

NeuBase Therapeutics (NASDAQ: NBSE) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

NeuBase Therapeutics, Inc.  (NBSE) 
Last neubase therapeutics, inc. earnings: 3/26 04:05 pm Check Earnings Report